JPH01210442A - Linear low-density polyethylene resin composition for medical container - Google Patents
Linear low-density polyethylene resin composition for medical containerInfo
- Publication number
- JPH01210442A JPH01210442A JP63034103A JP3410388A JPH01210442A JP H01210442 A JPH01210442 A JP H01210442A JP 63034103 A JP63034103 A JP 63034103A JP 3410388 A JP3410388 A JP 3410388A JP H01210442 A JPH01210442 A JP H01210442A
- Authority
- JP
- Japan
- Prior art keywords
- zeolite
- linear low
- density polyethylene
- resin composition
- density
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000092 linear low density polyethylene Polymers 0.000 title claims description 23
- 239000004707 linear low-density polyethylene Substances 0.000 title claims description 22
- 239000011342 resin composition Substances 0.000 title claims description 13
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims abstract description 61
- 239000010457 zeolite Substances 0.000 claims abstract description 51
- 229910021536 Zeolite Inorganic materials 0.000 claims abstract description 46
- 239000002245 particle Substances 0.000 claims abstract description 27
- 229910000323 aluminium silicate Inorganic materials 0.000 claims abstract description 15
- 238000010306 acid treatment Methods 0.000 claims description 5
- 230000005611 electricity Effects 0.000 abstract description 10
- 239000000203 mixture Substances 0.000 abstract description 10
- 230000003068 static effect Effects 0.000 abstract description 10
- 229910052751 metal Inorganic materials 0.000 abstract description 9
- 239000002184 metal Substances 0.000 abstract description 9
- 238000000465 moulding Methods 0.000 abstract description 9
- 238000000071 blow moulding Methods 0.000 abstract description 8
- 230000001954 sterilising effect Effects 0.000 abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 6
- 239000004698 Polyethylene Substances 0.000 abstract description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract description 2
- 239000005977 Ethylene Substances 0.000 abstract description 2
- 239000002253 acid Substances 0.000 abstract description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 abstract description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 abstract description 2
- 239000004711 α-olefin Substances 0.000 abstract description 2
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 description 8
- 229910052736 halogen Inorganic materials 0.000 description 6
- 150000002367 halogens Chemical class 0.000 description 6
- 238000001802 infusion Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 230000007797 corrosion Effects 0.000 description 5
- 238000005260 corrosion Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 3
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 229910001701 hydrotalcite Inorganic materials 0.000 description 3
- 229960001545 hydrotalcite Drugs 0.000 description 3
- 229920001684 low density polyethylene Polymers 0.000 description 3
- 239000004702 low-density polyethylene Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 239000002516 radical scavenger Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 101000941450 Lasioglossum laticeps Lasioglossin-1 Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000005341 cation exchange Methods 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910000975 Carbon steel Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000010962 carbon steel Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- JYIMWRSJCRRYNK-UHFFFAOYSA-N dialuminum;disodium;oxygen(2-);silicon(4+);hydrate Chemical compound O.[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Al+3].[Al+3].[Si+4] JYIMWRSJCRRYNK-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000012760 heat stabilizer Substances 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052665 sodalite Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は医療容器用直鎖状低密度ポリエチレン樹脂組成
物に関するものである。さらに詳しくいえば、本発明は
、医療容器、特に輸液用容器の基材として好適に用いら
れる、ブロー成形時において、成形機や金型の腐食が極
めて少なく、かつパリソンへの静電気の発生を防止する
ことができる上、加熱滅菌処理時に内蔵物への溶出のな
い医療容器を提供できるなど、優れた特徴を有する医療
容器用直鎖状低密度ポリエチレン樹脂組成物に関するも
のである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a linear low-density polyethylene resin composition for medical containers. More specifically, the present invention is suitable for use as a base material for medical containers, especially infusion containers, and has extremely low corrosion of the molding machine and mold during blow molding, and prevents the generation of static electricity on the parison. The present invention relates to a linear low-density polyethylene resin composition for medical containers that has excellent features such as being able to provide medical containers that do not elute into internal contents during heat sterilization.
[従来の技術]
従来、輸液用容器などの医療容器には、一般に軟質塩化
ビニル樹脂が用いられていt;。しかしながら、この軟
質塩化ビニル樹脂製のものは、加工性、機械的強度、透
明性、耐寒性などの諸性能に優れている反面、樹脂組成
物中に含まれている添加剤、特に可塑剤などが、容器の
内蔵物中に溶出し、生体に対する安全性が損なわれるお
それがあるという欠点を宵していた。したがって、この
ような軟質塩化ビニル樹脂製の医療容器に代わるものと
して、種々の可視性合成樹脂の使用が検討されており、
中でも、安全性が高く、優れた物性を有し、かつ価格的
にも安価であるポリオレフィン系樹脂の使用が試みられ
ている。[Prior Art] Conventionally, soft vinyl chloride resin has generally been used for medical containers such as infusion containers. However, although products made of soft vinyl chloride resin have excellent performance such as processability, mechanical strength, transparency, and cold resistance, they do not contain additives, especially plasticizers, etc. contained in the resin composition. However, it has had the disadvantage that it may elute into the internal contents of the container, impairing its safety for living organisms. Therefore, the use of various visible synthetic resins is being considered as an alternative to such medical containers made of soft vinyl chloride resin.
Among these, attempts have been made to use polyolefin resins, which are highly safe, have excellent physical properties, and are inexpensive.
ところで、直鎖状低密度ポリエチレンは、従来の低密度
ポリエチレンに比べて、工不ルギーコストが低い上に、
剛性、衝撃強度、耐ストレスクラック性などの機械的性
質や、耐熱性、耐寒性などに優れていることから、近年
特に注目され、種々の分野において、その利用が試みら
れている。By the way, linear low-density polyethylene has lower manufacturing and labor costs than conventional low-density polyethylene, and
Due to its excellent mechanical properties such as rigidity, impact strength, and stress crack resistance, as well as heat resistance and cold resistance, it has attracted particular attention in recent years, and its use has been attempted in various fields.
このような直鎖状低密度ポリエチレンは、輸液用容器な
どの医療容器の基材としても有望視されているが、該直
鎖状低密度ポリエチレンには、通常製造時に用いた触媒
に起因するハロゲン化合物が含まれているので、医療容
器を作製するためにそのままブロー成形しようとすると
、ブロー成形機や金型などの金属腐食を免れない。した
がって従来、防錆効果を発揮するハロゲン捕捉剤、例え
ばハイドロタルサイトや(特開昭52−49258号公
報)、金属セッケンなどを該直鎖状低密度ポリエチレン
に添加することが試みられている。Such linear low-density polyethylene is also seen as a promising base material for medical containers such as infusion containers, but linear low-density polyethylene usually contains halogens caused by catalysts used during manufacturing. Because it contains chemical compounds, if you try to blow mold it directly to make medical containers, you will inevitably suffer metal corrosion in the blow molding machine, mold, etc. Therefore, attempts have been made heretofore to add halogen scavengers, such as hydrotalcite (Japanese Unexamined Patent Publication No. 52-49258), metal soaps, etc., to the linear low-density polyethylene to exhibit a rust-preventing effect.
しかしながら、ハイドロタルサイトを添加する方法は、
一応の防錆効果を発揮するものの、ブロー成形時に、パ
リソンに静電気が著しく発生し、連続成形が困難である
という欠点を有している。However, the method of adding hydrotalcite is
Although it exhibits a certain degree of rust prevention effect, it has the drawback that static electricity is generated significantly in the parison during blow molding, making continuous molding difficult.
まI:、金属セッケンを添加する方法も、防錆効果を発
揮するものの、成形した容器を加熱滅菌処理する際に、
容器内蔵物中に該金属セッケンが溶出するおそれがある
という問題を有している。I: The method of adding metal soap also exhibits a rust prevention effect, but when the molded container is heat sterilized,
There is a problem that the metal soap may be eluted into the contents of the container.
[発明が解決しようとする課題]
本発明は、このような事情のもとで、ブロー成形時にお
いて、成形機や金型の腐食が極めて少なく、かつパリソ
ンへの静電気の発生を防止することができる上、加熱滅
菌処理時に内蔵物への溶出のない医療容器を提供しうる
なと、優れた特徴を有する医療容器用直鎖状低密度ポリ
エチレン樹脂組成物を提供することを目的としてなされ
たものである。[Problems to be Solved by the Invention] Under these circumstances, the present invention provides a method that minimizes corrosion of the molding machine and mold during blow molding and prevents the generation of static electricity on the parison. The purpose of this invention is to provide a linear low-density polyethylene resin composition for medical containers that has excellent characteristics, such as being able to provide medical containers that do not elute into internal contents during heat sterilization. It is.
[課題を解決するための手段]
本発明者らは、前記の優れた特徴を有する医療容器用直
鎖状低密度ポリエチレン樹脂組成物を開発するために鋭
意研究を重ねた結果、直鎖状低密度ポリエチレンに対し
て、ハロゲン捕捉剤としてゼオライトや特定のアルミノ
シリケートを特定の割合で配合したものが、・その目的
に適合しうろことを見い出し、この知見に基づいて本発
明を完成するに至った。[Means for Solving the Problems] The present inventors have conducted intensive research to develop a linear low-density polyethylene resin composition for medical containers having the above-mentioned excellent characteristics. It was discovered that a material containing a specific ratio of zeolite or a specific aluminosilicate as a halogen scavenger to density polyethylene is suitable for the purpose, and based on this knowledge, the present invention was completed. .
すなわち、本発明は、(A)直鎖状低密度ポリエチレン
100重量部に対し、(B)ゼオライト及び/又はゼオ
ライトを酸処理して得られたゼオライトの基本粒子形態
を具備する非晶質アルミノシリケート0.001〜0.
2重量部を添加して成る医療容器用直鎖状低密度ポリエ
チレン樹脂組成物を提供するものである。That is, the present invention provides (A) 100 parts by weight of linear low-density polyethylene, (B) zeolite and/or an amorphous aluminosilicate having the basic particle form of zeolite obtained by acid-treating the zeolite. 0.001~0.
The present invention provides a linear low-density polyethylene resin composition for medical containers, which contains 2 parts by weight of the present invention.
以下、本発明の詳細な説明する。The present invention will be explained in detail below.
本発明組成物において、(A)成分として用いられる直
鎖状低密度ポリエチレンとしては、エチレンと、好まし
くは0.2〜20モル%、より好ましくは1−10モル
%の炭素数3〜10のa−オレフィンの少なくとも1種
とを、液相又は気相で共重合させて成るものを挙げるこ
とができる。In the composition of the present invention, the linear low density polyethylene used as component (A) contains ethylene and preferably 0.2 to 20 mol%, more preferably 1 to 10 mol% of carbon atoms having 3 to 10 carbon atoms. Examples include those obtained by copolymerizing at least one a-olefin in a liquid phase or a gas phase.
前記a−オレフィンとしては、例えばプロピレン、ブテ
ン−11ペンテン−11ヘキセン−11へブテン−1、
オクテン−11ノネン−11デセン−1,4−メチルペ
ンテン−1,4−メチルヘキセン−1,4,4−ジメチ
ルペンテン−1などが挙げられる。このような直鎖状低
密度ポリエチレンとしては、密度が0.900〜0.9
60g/cm3、好ましくは0.910〜0.9259
/ cm3の範囲にあり、かつメルトインデックス(M
I )が0.1〜lOgZlO分、好ましくは0.5
〜4.0g/10分の範囲のあるものが好適である。Examples of the a-olefin include propylene, butene-11pentene-11hexene-11butene-1,
Examples include octene-11nonene-11decene-1,4-methylpentene-1,4-methylhexene-1,4,4-dimethylpentene-1. Such linear low density polyethylene has a density of 0.900 to 0.9.
60g/cm3, preferably 0.910-0.9259
/ cm3, and the melt index (M
I) is 0.1 to lOgZlO, preferably 0.5
A range of ˜4.0 g/10 minutes is suitable.
通常の低密度ポリエチレンは、前記の直鎖状低密度ポリ
エチレンに比べて耐熱性に劣るので、このものを医療用
容器の基材として用いた場合、該容器を加熱滅菌する際
に、容器が破損するおそれがある。また、該直鎖状低密
度ポリエチレンには、所望に応じ、高圧法低密度ポリエ
チレンや高密度ポリエチレンを0.1〜40重量%の範
囲で配合してもよい。Ordinary low-density polyethylene has inferior heat resistance compared to the linear low-density polyethylene described above, so if this material is used as a base material for medical containers, the containers may be damaged during heat sterilization. There is a risk of Further, if desired, high-pressure low density polyethylene or high density polyethylene may be blended in the linear low density polyethylene in a range of 0.1 to 40% by weight.
本発明組成物においては、(B)成分として、ゼオライ
ト、及び/又はゼオライトを酸処理して得られたゼオラ
イトの基本粒子形態を具備する非晶質アルミノシリケー
トが用いられる。前者のゼオライトは、一般式
%式%
(式中のMはNa又はそれと当量の一価若しくは多価金
属、Xは、1.5〜2,0、yは0〜10の数である)
で表される化学組成とX線回折により識別することので
きる独特の結晶構造を有するアルミノケイ酸塩であり、
天然のものであってもよいし、合成品であってもよい。In the composition of the present invention, as component (B), zeolite and/or an amorphous aluminosilicate having the basic particle form of zeolite obtained by acid treatment of zeolite is used. The former zeolite has the general formula % (M in the formula is Na or a monovalent or polyvalent metal equivalent thereto, X is a number from 1.5 to 2,0, and y is a number from 0 to 10). It is an aluminosilicate with a unique crystal structure that can be identified by expressed chemical composition and X-ray diffraction,
It may be a natural product or a synthetic product.
このようなゼオライトとしては、例えばA型ゼオライト
、P型ゼオライト、X型ゼオライト、Y型ゼオライト、
ソーダライト、アナルサイムなどを挙げることができ、
これらはそれぞれ単独で用いてもよいし、2種以上を組
み合わせて用いてもよい。本発明においては、これらの
ゼオライトの中で、球状に近いA型ゼオライト及びX型
ゼオライトが好ましく、特に工業的見地からA!ゼオラ
イトが好適である。Examples of such zeolites include A-type zeolite, P-type zeolite, X-type zeolite, Y-type zeolite,
Examples include sodalite, analcyme, etc.
These may be used alone or in combination of two or more. In the present invention, among these zeolites, A-type zeolite and X-type zeolite, which are nearly spherical, are preferred, and A! zeolite is particularly preferred from an industrial standpoint. Zeolites are preferred.
該A型ゼオライトは、一般式
%式%)
(式中のMはアルカリ金属又はアルカリ土類金属、nは
Mの原子価である。)
で表される結晶性アルミノケイ酸塩であり、カチオン交
換能を有し、等軸晶系に属する結晶゛構造を有している
。A型ゼオライトとしては、例えばナトリウムA型ゼオ
ライト、カリウムAmゼオライト、カルシウムA型ゼオ
ライト、マグネシウムA型ゼオライトなどを挙げること
ができ、これらは1種用いてもよいし、2種以上を組み
合わせて用いてもよく、また、これらのカチオンが同一
結晶体中に混在したものであってもよい。The A-type zeolite is a crystalline aluminosilicate represented by the general formula % (in which M is an alkali metal or alkaline earth metal, and n is the valence of M), and is a cation-exchangeable zeolite. It has a crystal structure belonging to an equiaxed crystal system. Examples of A-type zeolite include sodium A-type zeolite, potassium Am zeolite, calcium A-type zeolite, magnesium A-type zeolite, etc., and these may be used alone or in combination of two or more. Alternatively, these cations may be mixed in the same crystal.
一方、後者の非晶質アルミノシリケートとしては、ゼオ
ライトを酸処理して得られたゼオライトの基本的粒子形
態を具備しているものが用いられる。このものは、ゼオ
ライトの粒子形状や粒度分布状態などの基本的粒子形態
を具備してはいるものの、非晶質であって、ゼオライト
のような結晶構造を有していない。On the other hand, as the latter amorphous aluminosilicate, one having the basic particle form of zeolite obtained by acid treatment of zeolite is used. Although this material has the basic particle shape and particle size distribution of zeolite, it is amorphous and does not have a crystalline structure like zeolite.
このような非晶質アルミノシリケートは、ゼオライトを
酸処理することによって得られる。該酸処理は、例えば
ゼオライトの水性スラリーに、硫酸やリン酸などの酸又
は酸性物質を添加し、pHを4.5〜9、好ましくは5
〜7の弱酸性に調整することによって行われる。このp
l(が4.5未満ではゼオライトの粒子形状や粒度分布
状態などの基本的粒子形態が著しく変化したり、粒子全
体が溶解したりするので好ましくないし、pHが9を超
えると非晶質化しにくいので好ましくない。Such amorphous aluminosilicate is obtained by acid-treating zeolite. The acid treatment is performed, for example, by adding an acid or an acidic substance such as sulfuric acid or phosphoric acid to an aqueous slurry of zeolite to adjust the pH to 4.5 to 9, preferably 5.
This is done by adjusting the acidity to a weak acidity of ~7. This p
When l( is less than 4.5, the basic particle morphology such as the particle shape and particle size distribution state of the zeolite changes significantly, or the entire particle dissolves, which is undesirable. When the pH exceeds 9, it is difficult to become amorphous. So I don't like it.
この非晶質アルミノシリケートは、通常Na型のもので
あり、またゼオライトに特有のカチオン交換能は実質的
に消失しているが、僅かに残存しているカチオン交換能
により、Na+を他のカチオン、例えば(a++、Mg
++、Ba”、zn++、pb++などと置換させるこ
ともできる。さらに、アルミニウム、チタン、ジルコニ
ウム、アンチモンなどの金属水酸化物や、不定形シリカ
などで被覆処理を行うこともできる。This amorphous aluminosilicate is usually of the Na type, and although the cation exchange ability characteristic of zeolites has virtually disappeared, the slight remaining cation exchange ability allows Na+ to be exchanged with other cations. , for example (a++, Mg
++, Ba'', zn++, pb++, etc. It is also possible to perform coating treatment with metal hydroxides such as aluminum, titanium, zirconium, antimony, amorphous silica, etc.
ここでいう非晶質アルミノシリケートには、X線回折の
回折図から回折線が全く認められないもののみでなく、
回折線の高さがゼオライトの半分以下に低下して、実質
的に非晶質化しているものも包含する。The amorphous aluminosilicate referred to here includes not only those in which no diffraction lines are observed in the X-ray diffraction diagram, but also
It also includes those in which the height of the diffraction line is reduced to less than half that of zeolite and is substantially amorphous.
また、該非晶質アルミノシリケートの原料であるゼオラ
イトは、天然のものであってもよいし、合成品であって
もよいが、S r 02 / A Q z Oiモル比
が5以下、特に4以下のものは、酸処理により、その独
特の結晶構造が分解しやすいので好適である。このよう
なゼオライトとしては、例えばA型ゼオライト、P型ゼ
オライト、X型ゼオライト、Y型ゼオライトなどが挙げ
られ、これらは1種用いてもよいし、2種以上を組み合
わせて用いてもよい。特に、これらの中で、球状に近い
A型ゼオライトやX型ゼオライトを用いることが好まし
い。In addition, the zeolite that is the raw material for the amorphous aluminosilicate may be a natural product or a synthetic product, but the zeolite has a S r 02 / A Q z Oi molar ratio of 5 or less, particularly 4 or less. This is preferable because its unique crystal structure is easily decomposed by acid treatment. Examples of such zeolites include A-type zeolite, P-type zeolite, X-type zeolite, Y-type zeolite, etc., and these may be used alone or in combination of two or more types. Among these, it is particularly preferable to use type A zeolite and type X zeolite, which are nearly spherical.
本発明においては、(B)成分のゼオライト及び非晶質
アルミノシリケートは、平均粒子径が0 、5〜577
m 、特に1.5〜3.5.umの範囲のものが好ま
しく、さらに、平均粒子径の0.5〜1.5倍の範囲の
径を有する粒子の粒度分布が全体の50%以上を占める
ものが好適である。また、このCB)成分は、粒子形状
が球状ないし稜がとれた丸味のある立方体状のもので、
かつその粒子表面が滑らかであるものが好ましい。In the present invention, the zeolite and amorphous aluminosilicate as component (B) have an average particle diameter of 0.5 to 577.
m, especially 1.5 to 3.5. It is preferable that the particle size is in the range of 0.5 to 1.5 times the average particle size, and that the particle size distribution of the particles is 50% or more of the total particle size. In addition, this CB) component has a spherical or rounded cubic particle shape,
It is also preferable that the particle surface is smooth.
本発明組成物においては、前記CB)成分の添加量は、
(A)成分の直鎖状低密度ポリエチレン100重量部に
対して、0.001〜0.2重量部、好ましくはO,,
01〜0,1重量部の範囲で選ばれる。この添加量が0
.001重量部未満では本発明の目的が十分に達せられ
ないし、0.10重量部を超えるとタロー成形時にパリ
ソンへの静電気の発生が著しく、連続成形性が悪化する
傾向が生じる。In the composition of the present invention, the amount of the component CB) added is as follows:
0.001 to 0.2 parts by weight, preferably O,
The amount is selected within the range of 0.01 to 0.1 parts by weight. This addition amount is 0
.. If it is less than 0.001 part by weight, the object of the present invention cannot be fully achieved, and if it exceeds 0.10 part by weight, static electricity will be generated significantly on the parison during tallow molding, and continuous moldability will tend to deteriorate.
本発明組成物には、所望に応じ、帯電防止剤、フェノー
ル系やリン系の酸化防止剤、紫外線吸収剤、熱安定剤な
どを添加することができるが、ブリードしやすいものの
添加は好ましくない。If desired, antistatic agents, phenolic or phosphorus antioxidants, ultraviolet absorbers, heat stabilizers, etc. can be added to the composition of the present invention, but it is not preferable to add substances that tend to bleed.
本発明組成物の調製は常法により行うことができる。例
えば、前記(A) 、(B)成分及び所望に応じて前記
各種添加剤を、ニーグー、バンバリーミキサ−などの混
練機や1軸又は2軸押臼機などを用いて混練することに
より、調製することができる。また、本発明組成物を基
材とする医療容器の製造法としては、従来容器製造に慣
用されているブロー成形法を適用することができる。例
えば、該医療容器として、輸液用容器を製造する場合は
、本発明の直鎖状低密度ポリエチレン樹脂組成物を、ブ
ロー成形によって、所定形状の開口部、肩部、胴部を一
体的に形成したのち、胴部の側方及び下方周縁部を、そ
の内方において、インパルスシールやヒートシールによ
り溶着することによって、胴部の内側と外側の圧力差に
より、胴部周縁近辺部が容易に潰れうるような輸液用容
器を製造することができる。The composition of the present invention can be prepared by conventional methods. For example, the above (A) and (B) components and the various additives as desired may be kneaded using a kneading machine such as a Nigu or Banbury mixer, a single-screw or twin-screw mill, etc. can do. Furthermore, as a method for manufacturing medical containers using the composition of the present invention as a base material, a blow molding method conventionally used for manufacturing containers can be applied. For example, when manufacturing an infusion container as the medical container, the linear low-density polyethylene resin composition of the present invention is blow molded to integrally form an opening, a shoulder, and a body in a predetermined shape. Then, by welding the side and lower periphery of the body inwardly using impulse sealing or heat sealing, the area near the periphery of the body can be easily crushed due to the pressure difference between the inside and outside of the body. It is possible to manufacture a liquid infusion container that is moist.
本発明の樹脂組成物は、このようなブロー成形において
、成形機や金型をほとんど腐食することがなく、また、
パリソンへの静電気の発生も極めて少ない。さらに、得
られた容器を加熱滅菌処理する際、内蔵物への溶出がな
く、かつ容器が破損することもない。The resin composition of the present invention hardly corrodes the molding machine or mold during such blow molding, and
There is also very little static electricity generated on the parison. Furthermore, when the obtained container is subjected to heat sterilization treatment, there is no elution into the internal contents, and there is no damage to the container.
[発明の効果]
本発明の医療容器用直鎖状低密度ポリエチレン樹脂組成
物は、直鎖状低密度ポリエチレンにゼオライトや特定の
非晶質アルミノシリケートを添加したものであって、ブ
ロー成形時において、成形機や金型の腐食が極めて少な
く、かつパリソンへの静電気の発生を防止することがで
きる上、加熱滅菌処理時に内蔵物への溶出のない医療容
器を提供しうるなど、優れた特徴を有しており、特に輸
液用容器の基材として好適に用いられる。[Effects of the Invention] The linear low-density polyethylene resin composition for medical containers of the present invention is made by adding zeolite and a specific amorphous aluminosilicate to linear low-density polyethylene, and during blow molding, It has excellent features such as extremely little corrosion of the molding machine and mold, the ability to prevent the generation of static electricity on the parison, and the ability to provide medical containers that do not elute into internal contents during heat sterilization. It is particularly suitable for use as a base material for containers for infusions.
[実施例]
次に、実施例により本発明をさらに詳細に説明するが、
本発明はこれらの例によってなんら限定されるものでは
ない。[Example] Next, the present invention will be explained in more detail with reference to Examples.
The present invention is not limited in any way by these examples.
なお、組成物の各物性は次の方法に従って評価しt二。In addition, each physical property of the composition was evaluated according to the following method.
(1)腐食性 プレス腐食試験法を用いて評価した。(1) Corrosiveness It was evaluated using the press corrosion test method.
すなわち、5IOC炭素鋼から成る金属片上に、250
℃、5 kg/ cm”の条件で、30分間要して樹脂
組成物をプレス成形して試験片を作製し、この試験片を
5日間加湿処理したのち、金属片の色相(ハンター色座
標、a″値)を、スガ試験機(株)製のカラーコンピュ
ーターで評価した。a″が大きいほど、腐食性が大きい
ことを示す。That is, on a piece of metal consisting of 5IOC carbon steel, 250
℃ and 5 kg/cm" for 30 minutes to prepare a test piece. After humidifying this test piece for 5 days, the hue of the metal piece (Hunter color coordinates, a″ value) was evaluated using a color computer manufactured by Suga Test Instruments Co., Ltd. The larger a″ is, the higher the corrosivity is.
(2)静電気発生度 パリソンの静電気発生度合を、灰飛来法により求めた。(2) Static electricity generation rate The degree of static electricity generation in the parison was determined by the ash flying method.
すなわち、樹脂温度160℃、吐出量5 kg/ h
rの成形条件で実施し、灰がパリソンに付着するまでの
最長距離をもって、静電気の発生度合を数値化した。That is, resin temperature 160℃, discharge amount 5 kg/h
The molding was carried out under the molding conditions of r, and the degree of static electricity generation was quantified based on the longest distance until the ash adhered to the parison.
(3)溶出性
樹脂組成物ペレット20gを適当な硬質ガラス容器にと
り、0.45μmのフィルターろ過水にて十分に洗浄し
たのち、これに0.45μmのフィルターでろ過した生
理食塩液200m(1を加え、110°Cで40分間滅
菌処理し、次いで冷却しt;のち、コールタ−カウンタ
ーを用いて、2μm以上の粒子数を測定し、溶出性を評
価した。(3) Place 20 g of the eluable resin composition pellets in a suitable hard glass container, wash thoroughly with 0.45 μm filtered water, and add 200 m of physiological saline solution (1) filtered through a 0.45 μm filter. In addition, the mixture was sterilized at 110°C for 40 minutes, and then cooled; thereafter, the number of particles of 2 μm or more was measured using a Coulter counter to evaluate dissolution properties.
また、直鎖状低密度ポリエチレン及びハロゲン捕捉剤と
して次のものを用いた。In addition, the following were used as the linear low density polyethylene and the halogen scavenger.
直鎖状低密度ポリエチレン
(1)LL−I :MI=2.09/10分、密度=
0.91527cm”、
α−オレフィン−オクテン−1
(2)LL−n :MI =2.09710分、密度=
0.915 g/cm3、
α−オレフィンニブテン−1
(3)LL−I[[:MI = 1.3g/l 0分、
密度= 0.915 g7cm”、
a−オレフィン−オクテン−1
ハロゲン捕捉剤
(1)ジルトンM(水沢化学工業(株)製)M9−A型
ゼオライト、平均粒子径2.0μm1平均粒子径の0.
5〜1.5倍の範囲の径を有する粒子の含有量90%
(2)ジルトンAM(水沢化学工業(株)製)非晶質ア
ルミノシリケート(N a −4A型ゼオライトの硫酸
魁理品)、平均粒子径2.0μm1平均粒子径の0.5
〜1.5倍の範囲の径を有する粒子の含有量80%
(3)カルステS(日本油脂(株)製)金属セッケン(
ステアリン酸カルシウム)(4)DHT−4A(協和化
学工業(株)製)ハイドロタルサイト
実施例1〜11.比較例1〜9
各種直鎖状低密度ポリエチレン100重量部に、各種ハ
ロゲン捕捉剤を添加して又は添加せずに第1表に示す樹
脂組成物を調製し、その物性を評価した。結果を該表に
示す。Linear low density polyethylene (1) LL-I: MI = 2.09/10 min, density =
0.91527 cm", α-olefin-octene-1 (2) LL-n: MI = 2.09710 min, density =
0.915 g/cm3, α-olefin nibten-1 (3) LL-I[[:MI = 1.3 g/l 0 min,
Density = 0.915 g7cm", a-olefin-octene-1 Halogen scavenger (1) Zilton M (manufactured by Mizusawa Chemical Industry Co., Ltd.) M9-A type zeolite, average particle size 2.0 μm 1 average particle size 0.
90% content of particles having a diameter in the range of 5 to 1.5 times , average particle size 2.0 μm 1 average particle size 0.5
80% content of particles with a diameter in the range of ~1.5 times (3) Karste S (manufactured by NOF Corporation) metal soap (
Calcium stearate) (4) DHT-4A (manufactured by Kyowa Chemical Industry Co., Ltd.) Hydrotalcite Examples 1 to 11. Comparative Examples 1 to 9 Resin compositions shown in Table 1 were prepared with or without the addition of various halogen scavengers to 100 parts by weight of various linear low-density polyethylenes, and their physical properties were evaluated. The results are shown in the table.
(以下余白)(Margin below)
Claims (1)
、(B)ゼオライト及び/又はゼオライトを酸処理して
得られたゼオライトの基本粒子形態を具備する非晶質ア
ルミノシリケート0.001〜0.2重量部を添加して
成る医療容器用直鎖状低密度ポリエチレン樹脂組成物。1 (A) 100 parts by weight of linear low density polyethylene, (B) zeolite and/or amorphous aluminosilicate having the basic particle form of zeolite obtained by acid treatment of zeolite 0.001 to 0 .2 parts by weight of a linear low-density polyethylene resin composition for medical containers.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63034103A JPH01210442A (en) | 1988-02-18 | 1988-02-18 | Linear low-density polyethylene resin composition for medical container |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63034103A JPH01210442A (en) | 1988-02-18 | 1988-02-18 | Linear low-density polyethylene resin composition for medical container |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01210442A true JPH01210442A (en) | 1989-08-24 |
Family
ID=12404941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63034103A Pending JPH01210442A (en) | 1988-02-18 | 1988-02-18 | Linear low-density polyethylene resin composition for medical container |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01210442A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2744755C1 (en) * | 2020-06-26 | 2021-03-15 | Федеральное государственное автономное образовательное учреждение высшего образования "Северо-Восточный федеральный университет имени М.К.Аммосова" | Polymer composite material with modified clinoptilolite and the method for its preparation |
JP2021512203A (en) * | 2018-02-02 | 2021-05-13 | ダブリュー・アール・グレース・アンド・カンパニー−コーンW R Grace & Co−Conn | Antacids for polymers |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59129240A (en) * | 1983-01-12 | 1984-07-25 | Toyo Soda Mfg Co Ltd | Low-density polyethylene resin composition |
-
1988
- 1988-02-18 JP JP63034103A patent/JPH01210442A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59129240A (en) * | 1983-01-12 | 1984-07-25 | Toyo Soda Mfg Co Ltd | Low-density polyethylene resin composition |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021512203A (en) * | 2018-02-02 | 2021-05-13 | ダブリュー・アール・グレース・アンド・カンパニー−コーンW R Grace & Co−Conn | Antacids for polymers |
US11643481B2 (en) | 2018-02-02 | 2023-05-09 | W.R. Grace & Co.-Conn. | Antacids for polymers |
RU2744755C1 (en) * | 2020-06-26 | 2021-03-15 | Федеральное государственное автономное образовательное учреждение высшего образования "Северо-Восточный федеральный университет имени М.К.Аммосова" | Polymer composite material with modified clinoptilolite and the method for its preparation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4046610B2 (en) | Hexahydrophthalic acid metal salts as nucleation additives for crystalline thermoplastic polymers | |
WO2008005143A1 (en) | Compositions comprising metal salts of hexahydrophthalic acid and methods of employing such compositions in polyolefin resins | |
US4785042A (en) | Polyethylene resin composition containing amorphous aluminosilicates for improved films | |
JPH01210442A (en) | Linear low-density polyethylene resin composition for medical container | |
US4704424A (en) | Thermoplastic materials | |
JP2012152933A (en) | Propylene-based resin injection-molded product | |
JPH02163143A (en) | Polyolefin-based resin composition | |
JPS62158737A (en) | Stabilized polyolefin composition | |
JPS59164348A (en) | Propylene copolymer composition | |
EP1668071B1 (en) | Improved nucleating additive formulations of bicyclo 2.2.1 heptane dicarboxylate salts | |
JP3697329B2 (en) | Polypropylene composition | |
KR100633788B1 (en) | Resin composition for a medical container | |
KR100474873B1 (en) | complex nuclear agent having a improve flowability and transparency and method for manufacturing thereof | |
JP4087266B2 (en) | Polypropylene resin composition and use thereof | |
JP3159322B2 (en) | Antimicrobial polyolefin composition | |
JPH0623274B2 (en) | Antibacterial polyolefin composition | |
KR100633787B1 (en) | Resin composition for a medical container | |
JP7382331B2 (en) | Antacid for polymers | |
JP2018111789A (en) | Propylene-based resin composition for radiation sterilization corresponding medical care kit formulation and medical care kit formulation thereof | |
JPH0680830A (en) | Polyolefin resin composition and film therefrom | |
JP3256816B2 (en) | Polyolefin resin composition and film | |
JP3604269B2 (en) | Polypropylene resin composition for medical containers | |
GB2220665A (en) | Polyolefin compositions | |
JPS636039A (en) | Polyethylene resin composition | |
JP2003137244A (en) | Blow molded container for medical use |